The Structure and Stability of the Monomorphic HLA-G Are Influenced by the Nature of the Bound Peptide

Journal of Molecular Biology

Volumn 397, Issue 2, 2010, Pages 467-480

  Walpole, Nicholas G ^a   Kjer Nielsen, Lars ^b   Kostenko, Lyudmila ^b   McCluskey, James ^b   Brooks, Andrew G ^b   Rossjohn, Jamie ^a   Clements, Craig S ^a  

^a Department of Physiology School of Biomedical Sciences   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

adaptive immunity; antigen presentation; human leukocyte antigen G, HLA G; innate immunity; structural immunology

Indexed keywords

ARGINYLISOLEUCYLISOLEUCYLPROPYLARGINYLHISTIDINYLLEUCYLGLUTAMINYLLEUCINE; HLA G ANTIGEN; LYSYLGLYCYLPROPYLPROPYLALANYLALANYLLEUCYLTHREONYLLEUCINE; LYSYLLEUCYLPROPYLGLUTAMINYLALANYLPHENYLALANYLTYROSYLISOLEUCYLLEUCINE; PEPTIDE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALPHA HELIX; ANTIGEN BINDING; ANTIGEN STRUCTURE; ARTICLE; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY; THERMOSTABILITY;

EID: 77349121319     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.01.052     Document Type: Article

References (56)

1. Archbold J.K., Macdonald W.A., Gras S., Ely L.K., Miles J.J., Bell M.J., et al. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 206 (2009) 209-219
2. Macdonald W.A., Purcell A.W., Mifsud N.A., Ely L.K., Williams D.S., Chang L., et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198 (2003) 679-691
3. Tynan F.E., Borg N.A., Miles J.J., Beddoe T., El-Hassen D., Silins S.L., et al. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I: implications for T-cell receptor engagement and T-cell immunodominance. J. Biol. Chem. 280 (2005) 23900-23909
4. Grimsley C., Kawasaki A., Gassner C., Sageshima N., Nose Y., Hatake K., et al. Definitive high resolution typing of HLA-E allelic polymorphisms: identifying potential errors in existing allele data. Tissue Antigens 60 (2002) 206-212
5. Lajoie J., Boivin A.-A., Jeanneau A., Faucher M.-C., and Roger M. Identification of six new HLA-G alleles with non-coding DNA base changes. Tissue Antigens 73 (2009) 379-380
6. Hoare H.L., Sullivan L.C., Pietra G., Clements C.S., Lee E.J., Ely L.K., et al. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 7 (2006) 256
7. O'Callaghan C.A., Tormo J., Willcox B.E., Braud V.M., Jakobsen B.K., Stuart D.I., et al. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1 (1998) 531-541
8. Strong R.K., Holmes M.A., Li P., Braun L., Lee N., and Geraghty D.E. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278 (2003) 5082-5090
9. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., and Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187 (1998) 813-818
10. Blaschitz A., Lenfant F., Mallet V., Hartmann M., Bensussan A., Geraghty D., et al. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur. J. Immunol. 27 (1997) 3380-3388
11. Chu W., Fant M.E., Geraghty D.E., and Hunt J.S. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-γ-activated macrophages but not placental fibroblasts. Hum. Immunol. 59 (1998) 435-442
12. Kovats S., Main E., Librach C., Stubblebine M., Fisher S., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220-223
13. McMaster M.T., Librach C.L., Zhou Y., Lim K.H., Janatpour M.J., DeMars R., et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immunol. 154 (1995) 3771-3778
14. Le Bouteiller P., Solier C., Proll J., Aguerre-Girr M., Fournel S., and Lenfant F. Mini symposium. The major histocompatibility complex in pregnancy: Part II. Placental HLA-G protein expression in vivo: where and what for?. Hum. Reprod. Update 5 (1999) 223-233
15. Diehl M., Munz C., Keilholz W., Stevanovic S., Holmes N., Loke Y.W., and Rammensee H.-G. Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6 (1996) 305-314
16. Lee N., Malacko A., Ishitani A., Chen M., Bajorath J., Marquardt H., and Geraghty D.E. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3 (1995) 591-600
17. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., and Geraghty D.E. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 171 (2003) 1376-1384
18. Clements C.S., Kjer-Nielsen L., McCluskey J., and Rossjohn J. Structural studies on HLA-G: implications for ligand and receptor binding. Hum. Immunol. 68 (2007) 220-226
19. Clements C.S., Kjer-Nielsen L., Kostenko L., Hoare H.L., Dunstone M.A., Moses E., et al. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc. Natl Acad. Sci. USA 102 (2005) 3360-3365
20. Shiroishi M., Kuroki K., Ose T., Rasubala L., Shiratori I., Arase H., et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 281 (2006) 10439-10447
21. Boyson J.E., Erskine R., Whitman M.C., Chiu M., Lau J.M., Koopman L.A., et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc. Natl Acad. Sci. USA 99 (2002) 16180-16185
22. Brown D., Trowsdale J., and Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64 (2004) 215-225
23. Chapman T.L., Heikema A.P., and Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11 (1999) 603-613
24. Gonen-Gross T., Achdout H., Arnon T.I., Gazit R., Stern N., Horejsi V., et al. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β2-microglobulin-free HLA-G molecules. J. Immunol. 175 (2005) 4866-4874
25. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl Acad. Sci. USA 100 (2003) 8856-8861
26. Shiroishi M., Kuroki K., Rasubala L., Tsumoto K., Kumagai I., Kurimoto E., et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc. Natl Acad. Sci. USA 103 (2006) 16412-16417
27. Yan W.H., and Fan L.A. Residues Met76 and Gln79 in HLA-G α1 domain involved in KIR2DL4 recognition. Cell Res. 15 (2005) 176
28. Boyington J.C., Motyka S.A., Schuck P., Brooks A.G., and Sun P.D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405 (2000) 537-543
29. Fan Q.R., Long E.O., and Wiley D.C. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat. Immunol. 2 (2001) 452-460
30. Munz C., Stevanovic S., and Rammensee H.-G. Peptide presentation and NK inhibition by HLA-G. J. Reprod. Immunol. 43 (1999) 139
31. Favier B., LeMaoult J., Rouas-Freiss N., Moreau P., Menier C., and Carosella E.D. Research on HLA-G: an update. Tissue Antigens 69 (2007) 207-211
32. Stewart-Jones G.B.E., di Gleria K., Kollnberger S., McMichael A.J., Jones E.Y., and Bowness P. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur. J. Immunol. 35 (2005) 341-351
33. Rajagopalan S., and Long E.O. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185 (1997) 1523-1528
34. Maenaka K., Juji T., Nakayama T., Wyer J.R., Gao G.F., Maenaka T., et al. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 274 (1999) 28329-28334
35. Brooks A.G., Borrego F., Posch P.E., Patamawenu A., Scorzelli C.J., Ulbrecht M., et al. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162 (1999) 305-313
36. Kaiser B.K., Barahmand-pour F., Paulsene W., Medley S., Geraghty D.E., and Strong R.K. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J. Immunol. 174 (2005) 2878-2884
37. Sullivan L.C., Clements C.S., Rossjohn J., and Brooks A.G. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 72 (2008) 415-424
38. Petrie E.J., Clements C.S., Lin J., Sullivan L.C., Johnson D., Huyton T., et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J. Exp. Med. 205 (2008) 725-735
39. Sullivan L.C., Clements C.S., Beddoe T., Johnson D., Hoare H.L., Lin J., et al. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. Immunity 27 (2007) 900-911
40. Rodgers J.R., and Cook R.G. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5 (2005) 459-471
41. Sullivan L.C., Hoare H.L., McCluskey J., Rossjohn J., and Brooks A.G. A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol. 27 (2006) 413
42. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162 (1999) 5398-5406
43. + cytolytic T lymphocytes. Proc. Natl Acad. Sci. USA 100 (2003) 10896-10901
44. + T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 173 (2004) 5852-5862
45. + T cells. J. Exp. Med. 196 (2002) 1473-1481
46. Lenfant F., Pizzato N., Liang S., Davrinche C., Le Bouteiller P., and Horuzsko A. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J. Gen. Virol. 84 (2003) 307-317
47. Degano M., Garcia K.C., Apostolopoulos V., Rudolph M.G., Teyton L., and Wilson I.A. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 12 (2000) 251-261
48. Godfrey D.I., Rossjohn J., and McCluskey J. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity 28 (2008) 304-314
49. Rudolph M.G., Stanfield R.L., and Wilson I.A. How TCRs bind MHCs, peptides and coreceptors. Annu. Rev. Immunol. 24 (2006) 419-466
50. Clements C.S., Kjer-Nielsen L., Kostenko L., McCluskey J., and Rossjohn J. The production, purification and crystallization of a soluble form of the nonclassical MHC HLA-G: the essential role of cobalt. Acta Crystallogr., Sect. F, Struct. Biol. Cryst. Commun. 62 (2006) 70-73
51. Clements C.S., Kjer-Nielsen L., MacDonald W.A., Brooks A.G., Purcell A.W., McCluskey J., and Rossjohn J. The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. Acta Crystallogr., Sect. D: Biol. Crystallogr. 58 (2002) 2131-2134
52. β deviation. Proteins: Struct., Funct., Genet. 50 (2003) 437-450
53. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
54. McCoy A.J., Grosse-Kunstleve R.W., Storoni L.C., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr., Sect. D: Biol. Crystallogr. 61 (2005) 458-464
55. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 50 (1994) 760-763
56. Adams P.D., Grosse-Kunstleve R.W., Hung L.-W., Ioerger T.R., McCoy A.J., Moriarty N.W., et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 58 (2002) 1948-1954